Faricimab versus the standard of care for neovascular age-related macular degeneration in Italy: an indirect treatment comparison
{{output}}
Objectives: To assess through an indirect treatment comparison (ITC) the potential benefit of faricimab over the anti-vascular endothelial growth factor (VEGF) real-life scenario, hereby defined standard of care (SoC), in Italy, ... ...
